SCHEMBL31723967

SCHEMBL31723967

NC(=O)CCCC(C(N)=O)N1C(=O)CCCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA3 P07451 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA13 Q8N1Q1 1/20 0.45
CA14 Q9ULX7 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
TSHR P16473 1/20 0.39
ALDH1A1 P00352 1/20 0.37
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
APEX1 P27695 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31723991 0.95 LMNA (0.44) LMNACA12CA1CA2CA3
SCHEMBL31723955 0.93 LMNA (0.40) LMNACA12CA1CA2CA3
SCHEMBL31723957 0.92 LMNA (0.46) LMNACA12CA1CA2CA3
SCHEMBL31723979 0.88 LMNA (0.39) LMNACA12CA1CA2CA3
SCHEMBL21820033 0.84 LMNA (0.41) LMNACA12CA1CA2CA3
SCHEMBL31723983 0.81 LMNA (0.49) LMNACA12CA1CA2CA3
SCHEMBL10409212 0.80 KMT2A (0.50) LMNACA12CA1CA2CA3
SCHEMBL8763337 0.78 CA2 (0.46) LMNACA12CA1CA2CA3
SCHEMBL6565960 0.78 HDAC3 (0.40) LMNACA12CA1CA2CA3
SCHEMBL31723987 0.76 KMT2A (0.36) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345488-A1 CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-11-13 US disclosed